Phone: 866.839.4840 | Fax: 732.905.7893

Archive for May, 2012

Posted on: May 7th, 2012 by Martek Pharmacal

The FDA has delayed its decision to approve the weight loss drug, Qnexa.  The target date has been pushed back to July 17 to consider a new drug safety plan submitted by the manufacturer, Vivus.   Previously the agency was scheduled to make a decision by April 17.  Vivus stated the three-month extension is standard when companies submit additional risk management information for a drug.
We are now completely out of the Bontril 35mg tablets and 105mg capsules.  If you were using these products, please contact us to discuss the generic alternatives.